TRK fusion-positive lung cancers

January 10, 2022 00:21:28
TRK fusion-positive lung cancers
COR2ED Medical Education
TRK fusion-positive lung cancers

Jan 10 2022 | 00:21:28

/

Show Notes

In this medical education podcast, NTRK CONNECT members Assoc. Prof. Caterina Marchiò (University of Turin, Italy) and Prof. Christian Rolfo (Center of Thoracic Oncology Tisch Cancer Institute Icahn School of Medicine at Mount Sinai, New York, USA) provide pathologist and medical oncologist perspectives about the detection and treatment of TRK fusion-positive lung cancers.

They discuss a number of techniques and strategies to identify this rare fusion in lung cancer patients, before going on to summarise the robust efficacy and safety data for both entrectinib and larotrectinib. Prof. Rolfo briefly covers second-generation therapies in clinical development and describes how liquid biopsy is emerging as a new technique not only to identify but also monitor patients. They conclude by stressing the importance of the collaboration and communication between pathologists and oncologists to test for and identify TRK fusion-positive lung cancer patients.

Other Episodes

Episode 22

September 21, 2023 00:25:45
Episode Cover

Severe PPH – Definitions and Real-World Incidence

COR2ED Medical Education: Dr Homa K. Ahmadzia (Maternal-Fetal Medicine specialist and Assistant Professor in the Department of Obstetrics and Gynecology at George Washington University...

Listen

Episode 1

September 12, 2022 00:16:37
Episode Cover

ASBMR 2022 Rare Bone Disease Highlights: Episode 1

In this first episode of a three-episode podcast series, COR2ED and ASBMR have partnered with Professor Anna Teti (University of L’Aquila) to provide rare...

Listen

Episode 1

July 28, 2022 00:22:00
Episode Cover

Prostate Cancer Highlights from ASCO GU, ASCO and EAUN 2022

Prostate Cancer Highlights from ASCO GU, ASCO and EAUN 2022 COR2ED Medical Education: In this podcast Dr Jason Alcorn and Jennifer Sutton discuss the...

Listen